Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
3.470
+0.050 (1.46%)
Aug 25, 2026, 4:00 PM EDT - Market closed
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $600.8 million as of August 25, 2026. Its market cap has increased by 578.11% in one year.
Market Cap
600.80M
Enterprise Value
589.92M
1-Year Change
578.11%
Ranking
Category
Stock Price
$3.47
ChartMarket Cap Chart
Since June 28, 2018, Entera Bio's market cap has increased from $71.40M to $600.80M, an increase of 741.46%. That is a compound annual growth rate of 29.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 600.80M | 575.06% |
| Dec 31, 2025 | 89.00M | 13.96% |
| Dec 31, 2024 | 78.10M | 351.45% |
| Dec 29, 2023 | 17.30M | -17.62% |
| Dec 30, 2022 | 21.00M | -74.07% |
| Dec 31, 2021 | 81.00M | 309.09% |
| Dec 31, 2020 | 19.80M | -23.85% |
| Dec 31, 2019 | 26.00M | -25.50% |
| Dec 31, 2018 | 34.90M | -51.12% |
| Jun 28, 2018 | 71.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sagimet Biosciences | 639.61M |
| MiMedx Group | 632.60M |
| Arvinas | 627.71M |
| Altimmune | 622.46M |
| Zura Bio | 605.64M |
| Scribe Therapeutics | 588.66M |
| REGENXBIO | 588.18M |
| Artiva Biotherapeutics | 575.44M |